HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- ‘Monumental’ and ‘highly meaningful’ advances across solid tumors highlight ESMO program Mark Leiser
-
- Acupuncture, massage reduce long-term pain among patients with advanced cancer Jennifer R. Southall
- Analysis shows high rate of ‘significant’ health problems in childhood cancer survivors Jennifer Byrne; Smita Bhatia, MD, MPH
- Burnout soars among US oncologists over past decade Jennifer Byrne
- 'Intentional' steps can minimize cancer miscommunication during patient encounters Jennifer Byrne; Donald R. Sullivan, MD, MA, MCR; William E. Rosa, PhD, MBE, APRN
- Combined PD-1, HER2 blockade extends PFS in gastric, gastroesophageal junction cancers Mark Leiser
- Early response may predict outcomes in heavily pretreated chronic myeloid leukemia Mark Leiser
- Emicizumab offers ‘new path forward’ for infants with severe hemophilia A Mark Leiser
- Fear of recurrence in survivorship: ‘Don’t shy away from it — learn from it’ Jennifer Byrne
-
- Fox Chase urologic oncology chair receives award for career achievement in kidney cancer Mark Leiser
- Harvard/Dana-Farber professor recognized for contributions to breast cancer research Mindy Valcarcel, MS
- Heterogeneity in germline susceptibility to renal cell carcinoma has genetic screening implications Mark Leiser
- Kidney Cancer Association presents rising star award Mark Leiser
- Liquid biopsy predicts radiotherapy benefit in metastatic lung cancer Matthew Shinkle
- Novel T-cell engager demonstrates activity in neuroendocrine carcinomas Mark Leiser
- ‘Our community is suffering’: Study aims to identify needs of Latino cancer survivors Jennifer Byrne
- Precision navigators reduce racial disparities in genomic testing for prostate cancer Jennifer R. Southall
-
- Ribociclib regimen provides durable benefit, reduces recurrence in breast cancer subgroup Mark Leiser
- Tailored interventions needed to address ‘catastrophic’ financial burdens of cancer care Jennifer R. Southall
- Tarlatamab active in previously treated small cell lung cancer Mark Leiser
- Text-based prescreening can reduce clinic time for immunotherapy recipients Matthew Shinkle
- Travel time linked to participation in genotype-matched cancer trials Mark Leiser
- ‘Unequivocal’ data emerges from trial of CLL therapy guided by measurable residual disease Mark Leiser
- University of Utah professor receives outstanding investigator award Mark Leiser
- Yoga-based intervention benefits patients with head and neck cancer Jennifer R. Southall
-
- Zanzalintinib a potential ‘novel breakthrough’ in advanced clear cell renal cell carcinoma Mark Leiser
- Bayer to withdraw lymphoma treatment Aliqopa from U.S. market Drew Amorosi
- FDA places partial hold on trials for T-cell lymphomas after patient death Drew Amorosi
- Sickle cell gene therapy ‘benefits far outweigh the risks,’ FDA adviser says Drew Amorosi
- ASH elects three to leadership positions Mark Leiser
- Breast cancer prevention pioneer honored with lecture award Mark Leiser
- Biden to appoint Vanderbilt oncologist as new NCI director Jennifer R. Southall
- Leukemia specialist receives award for impact in hematologic malignancies field
-
- National Comprehensive Cancer Network awards grants for small cell lung cancer research